

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.34317658 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.34317658 |
| 3 | exogenous drug catabolic process (GO:0042738) | 7.31493093 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.06437449 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.06437449 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.92208265 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.76102026 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.58281229 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.92518011 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.92518011 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.92518011 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 5.90888688 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.83346667 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.77675111 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.76711225 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.73388528 |
| 17 | urea metabolic process (GO:0019627) | 5.68139391 |
| 18 | urea cycle (GO:0000050) | 5.68139391 |
| 19 | drug metabolic process (GO:0017144) | 5.67586904 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.58901329 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.48972206 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.39969268 |
| 23 | cysteine metabolic process (GO:0006534) | 5.39515570 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36837789 |
| 25 | omega-hydroxylase P450 pathway (GO:0097267) | 5.34220745 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31098569 |
| 27 | protein carboxylation (GO:0018214) | 5.31098569 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.29960834 |
| 29 | reverse cholesterol transport (GO:0043691) | 5.28100998 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 5.25695832 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.22542058 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.21836405 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 5.17840949 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 5.06169764 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 5.06169764 |
| 36 | macromolecular complex remodeling (GO:0034367) | 5.06169764 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 5.02567373 |
| 38 | phospholipid efflux (GO:0033700) | 5.00120951 |
| 39 | bile acid metabolic process (GO:0008206) | 4.96083071 |
| 40 | regulation of complement activation (GO:0030449) | 4.92953197 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80956626 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.79922126 |
| 43 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.77970519 |
| 44 | phenylpropanoid metabolic process (GO:0009698) | 4.77370294 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.73309300 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 4.73309300 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.71909519 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 4.64303341 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.63449388 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.62063819 |
| 51 | cholesterol efflux (GO:0033344) | 4.54406554 |
| 52 | heme transport (GO:0015886) | 4.54172907 |
| 53 | * triglyceride homeostasis (GO:0070328) | 4.53719553 |
| 54 | * acylglycerol homeostasis (GO:0055090) | 4.53719553 |
| 55 | oxidative demethylation (GO:0070989) | 4.52473026 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.51330057 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.50855243 |
| 58 | lysine metabolic process (GO:0006553) | 4.50393737 |
| 59 | lysine catabolic process (GO:0006554) | 4.50393737 |
| 60 | hormone catabolic process (GO:0042447) | 4.46340764 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.42400902 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 4.39744597 |
| 63 | negative regulation of blood coagulation (GO:0030195) | 4.39667271 |
| 64 | negative regulation of hemostasis (GO:1900047) | 4.39667271 |
| 65 | glycine metabolic process (GO:0006544) | 4.38320641 |
| 66 | regulation of plasminogen activation (GO:0010755) | 4.28111658 |
| 67 | lipoprotein transport (GO:0042953) | 4.27331652 |
| 68 | cellular glucuronidation (GO:0052695) | 4.24619481 |
| 69 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.22143071 |
| 70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.22143071 |
| 71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.21107494 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.20116880 |
| 73 | alkaloid metabolic process (GO:0009820) | 4.18977613 |
| 74 | coenzyme catabolic process (GO:0009109) | 4.18308775 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 4.16956808 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 4.16878909 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.16764037 |
| 78 | glutamate metabolic process (GO:0006536) | 4.16560271 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.10039749 |
| 80 | amine catabolic process (GO:0009310) | 4.10039749 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 4.08055905 |
| 82 | fibrinolysis (GO:0042730) | 4.04718909 |
| 83 | aldehyde catabolic process (GO:0046185) | 4.04057897 |
| 84 | arginine metabolic process (GO:0006525) | 4.03521895 |
| 85 | negative regulation of coagulation (GO:0050819) | 4.03273506 |
| 86 | ketone body metabolic process (GO:1902224) | 4.01746537 |
| 87 | ethanol oxidation (GO:0006069) | 4.01594317 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00671893 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 3.99920741 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 3.99460335 |
| 91 | intestinal absorption (GO:0050892) | 3.99103167 |
| 92 | protein-lipid complex assembly (GO:0065005) | 3.96605806 |
| 93 | drug catabolic process (GO:0042737) | 3.96124527 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.95565848 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95229082 |
| 96 | daunorubicin metabolic process (GO:0044597) | 3.91205964 |
| 97 | polyketide metabolic process (GO:0030638) | 3.91205964 |
| 98 | doxorubicin metabolic process (GO:0044598) | 3.91205964 |
| 99 | negative regulation of wound healing (GO:0061045) | 3.90999762 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.88945430 |
| 101 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86585859 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 3.85104257 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.84796939 |
| 104 | * cholesterol homeostasis (GO:0042632) | 3.82195708 |
| 105 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77228536 |
| 106 | glucuronate metabolic process (GO:0019585) | 3.77098561 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.77098561 |
| 108 | negative regulation of lipase activity (GO:0060192) | 3.76601768 |
| 109 | * sterol homeostasis (GO:0055092) | 3.75919084 |
| 110 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.75869943 |
| 111 | lipoprotein metabolic process (GO:0042157) | 3.75567181 |
| 112 | intestinal cholesterol absorption (GO:0030299) | 3.70808483 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.70804213 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.70089722 |
| 115 | ethanol metabolic process (GO:0006067) | 3.68561440 |
| 116 | cofactor catabolic process (GO:0051187) | 3.68521663 |
| 117 | protein activation cascade (GO:0072376) | 3.68196428 |
| 118 | protein-lipid complex subunit organization (GO:0071825) | 3.67174466 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 3.65480837 |
| 120 | organic acid catabolic process (GO:0016054) | 3.65480837 |
| 121 | drug transmembrane transport (GO:0006855) | 3.65276128 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.64789870 |
| 123 | response to nitrosative stress (GO:0051409) | 3.64293434 |
| 124 | complement activation (GO:0006956) | 3.63861991 |
| 125 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.55235822 |
| 126 | drug transport (GO:0015893) | 3.55164419 |
| 127 | negative regulation of protein activation cascade (GO:2000258) | 3.53003399 |
| 128 | primary alcohol catabolic process (GO:0034310) | 3.49325626 |
| 129 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.40404711 |
| 130 | sterol transport (GO:0015918) | 3.38793749 |
| 131 | cholesterol transport (GO:0030301) | 3.38793749 |
| 132 | angiotensin maturation (GO:0002003) | 3.38139567 |
| 133 | xenobiotic metabolic process (GO:0006805) | 3.37937738 |
| 134 | regulation of sterol transport (GO:0032371) | 3.35117654 |
| 135 | regulation of cholesterol transport (GO:0032374) | 3.35117654 |
| 136 | steroid catabolic process (GO:0006706) | 3.34705651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33153488 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22300128 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.01539544 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45046654 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16485473 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.15959948 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.92342341 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.98089181 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97242849 |
| 10 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.19235442 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04222847 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0396370 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99266418 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59677266 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59234496 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50742559 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44705781 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40700357 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.30904003 |
| 20 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.28614202 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28246482 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25760959 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23880381 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21886486 |
| 25 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19385651 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14119834 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11495126 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09413941 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08868377 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07263350 |
| 31 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06713005 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06343377 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04460709 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01253670 |
| 35 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98580142 |
| 36 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95450632 |
| 37 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94731544 |
| 38 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94379394 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91708072 |
| 40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91049493 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85632130 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84689987 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83021848 |
| 44 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.82047432 |
| 45 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81846232 |
| 46 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81335963 |
| 47 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.80533182 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79765533 |
| 49 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79687870 |
| 50 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.78703077 |
| 51 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78638405 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78199156 |
| 53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77934219 |
| 54 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76054723 |
| 55 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74737122 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74111645 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73335240 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.72024892 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.71195817 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71123437 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.70242213 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.69473659 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69342910 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.68127926 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68063478 |
| 66 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.67840878 |
| 67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67817393 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67193309 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67129038 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.66606094 |
| 71 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66276590 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65192614 |
| 73 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.64997995 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.64825273 |
| 75 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.64622552 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64599390 |
| 77 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.64412745 |
| 78 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.63730383 |
| 79 | NFYA_21822215_ChIP-Seq_K562_Human | 0.63425989 |
| 80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63239644 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62404230 |
| 82 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.61915077 |
| 83 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.61797034 |
| 84 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.61534372 |
| 85 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.61076245 |
| 86 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.60688613 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.60217783 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.60217783 |
| 89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.59483454 |
| 90 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.59170203 |
| 91 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.58845238 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58477841 |
| 93 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.58295588 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.57889942 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.57881875 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.57881875 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 0.57795077 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.57551875 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56909895 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55376568 |
| 101 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54039448 |
| 102 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53986481 |
| 103 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53501758 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53180735 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52858865 |
| 106 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51160419 |
| 107 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.51053279 |
| 108 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49388217 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48483812 |
| 110 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48429743 |
| 111 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.47686924 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.47673797 |
| 113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47119181 |
| 114 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46577649 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46331804 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45280435 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45091673 |
| 118 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44990565 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44586884 |
| 120 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.43918281 |
| 121 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43403661 |
| 122 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43334394 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43063691 |
| 124 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42966237 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42935823 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.40080156 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39632147 |
| 128 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.38356602 |
| 129 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38190700 |
| 130 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37186205 |
| 131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36909715 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36718864 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36146187 |
| 134 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35986005 |
| 135 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35651438 |
| 136 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35503312 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.35475781 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.34805378 |
| 139 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34026664 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.33768445 |
| 141 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33739284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21747279 |
| 2 | MP0005360_urolithiasis | 7.85796853 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.33040207 |
| 4 | MP0005365_abnormal_bile_salt | 6.05080352 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.96773736 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.32745865 |
| 7 | MP0003252_abnormal_bile_duct | 3.89331004 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.68973263 |
| 9 | MP0009840_abnormal_foam_cell | 3.58247698 |
| 10 | MP0005083_abnormal_biliary_tract | 2.90224226 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.86201769 |
| 12 | MP0005332_abnormal_amino_acid | 2.71856721 |
| 13 | MP0003195_calcinosis | 2.64938551 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.46954787 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.21091206 |
| 16 | MP0000609_abnormal_liver_physiology | 2.14674290 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.07533168 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.87675099 |
| 19 | MP0003868_abnormal_feces_composition | 1.86237298 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.78895457 |
| 21 | MP0009697_abnormal_copulation | 1.73199295 |
| 22 | MP0001764_abnormal_homeostasis | 1.69112448 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54379362 |
| 24 | MP0005451_abnormal_body_composition | 1.51147019 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.49864684 |
| 26 | MP0003011_delayed_dark_adaptation | 1.45018331 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.29707215 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.26560719 |
| 29 | MP0003186_abnormal_redox_activity | 1.24669597 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.23016208 |
| 31 | MP0000598_abnormal_liver_morphology | 1.17028761 |
| 32 | MP0000604_amyloidosis | 1.09318745 |
| 33 | MP0005647_abnormal_sex_gland | 1.04689038 |
| 34 | MP0002254_reproductive_system_inflammat | 1.03835081 |
| 35 | MP0009764_decreased_sensitivity_to | 0.99936232 |
| 36 | MP0009763_increased_sensitivity_to | 0.98175969 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.96466555 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 0.93118849 |
| 39 | MP0010368_abnormal_lymphatic_system | 0.92902457 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.87789216 |
| 41 | MP0008469_abnormal_protein_level | 0.87629699 |
| 42 | MP0005408_hypopigmentation | 0.86551395 |
| 43 | MP0003879_abnormal_hair_cell | 0.86190661 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.83756337 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 0.82049203 |
| 46 | MP0002876_abnormal_thyroid_physiology | 0.78974823 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 0.76808740 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.75351453 |
| 49 | MP0005266_abnormal_metabolism | 0.70897327 |
| 50 | MP0009053_abnormal_anal_canal | 0.70472386 |
| 51 | MP0002971_abnormal_brown_adipose | 0.67534501 |
| 52 | MP0005220_abnormal_exocrine_pancreas | 0.66487962 |
| 53 | MP0005334_abnormal_fat_pad | 0.64878527 |
| 54 | MP0001986_abnormal_taste_sensitivity | 0.64492773 |
| 55 | MP0005058_abnormal_lysosome_morphology | 0.63212843 |
| 56 | MP0005670_abnormal_white_adipose | 0.61870463 |
| 57 | MP0000566_synostosis | 0.61656313 |
| 58 | MP0005535_abnormal_body_temperature | 0.61628578 |
| 59 | MP0003718_maternal_effect | 0.60513685 |
| 60 | MP0005409_darkened_coat_color | 0.60100829 |
| 61 | MP0005448_abnormal_energy_balance | 0.59780803 |
| 62 | MP0003329_amyloid_beta_deposits | 0.59365465 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.58975429 |
| 64 | MP0001756_abnormal_urination | 0.58440690 |
| 65 | MP0003690_abnormal_glial_cell | 0.58153135 |
| 66 | MP0004130_abnormal_muscle_cell | 0.57845072 |
| 67 | MP0001661_extended_life_span | 0.57683638 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.56233914 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.54503250 |
| 70 | MP0001915_intracranial_hemorrhage | 0.54153142 |
| 71 | MP0002822_catalepsy | 0.52586320 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 0.51466128 |
| 73 | MP0010155_abnormal_intestine_physiology | 0.51212232 |
| 74 | MP0005395_other_phenotype | 0.50599217 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 0.46962485 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.46939566 |
| 77 | MP0008873_increased_physiological_sensi | 0.46711371 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.46108212 |
| 79 | MP0002796_impaired_skin_barrier | 0.43376223 |
| 80 | MP0005023_abnormal_wound_healing | 0.43349933 |
| 81 | MP0005187_abnormal_penis_morphology | 0.43025882 |
| 82 | MP0003941_abnormal_skin_development | 0.41256896 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.41256264 |
| 84 | MP0005166_decreased_susceptibility_to | 0.41053374 |
| 85 | MP0003953_abnormal_hormone_level | 0.40352882 |
| 86 | MP0008872_abnormal_physiological_respon | 0.39723025 |
| 87 | MP0003436_decreased_susceptibility_to | 0.38841683 |
| 88 | MP0008874_decreased_physiological_sensi | 0.38050699 |
| 89 | MP0002928_abnormal_bile_duct | 0.37928166 |
| 90 | MP0003075_altered_response_to | 0.37722955 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.37524592 |
| 92 | MP0009384_cardiac_valve_regurgitation | 0.37252582 |
| 93 | MP0002090_abnormal_vision | 0.36807349 |
| 94 | MP0009672_abnormal_birth_weight | 0.36291996 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 0.34891610 |
| 96 | MP0003724_increased_susceptibility_to | 0.34705158 |
| 97 | MP0009115_abnormal_fat_cell | 0.34473520 |
| 98 | MP0009379_abnormal_foot_pigmentation | 0.34426187 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.33615685 |
| 100 | MP0004883_abnormal_blood_vessel | 0.33251286 |
| 101 | MP0000579_abnormal_nail_morphology | 0.32594888 |
| 102 | MP0000249_abnormal_blood_vessel | 0.32493536 |
| 103 | MP0004272_abnormal_basement_membrane | 0.32072374 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.32012368 |
| 105 | MP0001664_abnormal_digestion | 0.31403734 |
| 106 | MP0001243_abnormal_dermal_layer | 0.30673886 |
| 107 | MP0004381_abnormal_hair_follicle | 0.30480101 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.29533124 |
| 109 | MP0005410_abnormal_fertilization | 0.29478421 |
| 110 | MP0002132_abnormal_respiratory_system | 0.29252095 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.28890320 |
| 112 | MP0006082_CNS_inflammation | 0.28759467 |
| 113 | MP0001881_abnormal_mammary_gland | 0.28382059 |
| 114 | MP0002970_abnormal_white_adipose | 0.27020413 |
| 115 | MP0005164_abnormal_response_to | 0.26747419 |
| 116 | MP0000477_abnormal_intestine_morphology | 0.26372479 |
| 117 | MP0004147_increased_porphyrin_level | 0.26055929 |
| 118 | MP0000538_abnormal_urinary_bladder | 0.24895947 |
| 119 | MP0002168_other_aberrant_phenotype | 0.24385715 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.23630566 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.22919469 |
| 122 | MP0003890_abnormal_embryonic-extraembry | 0.20919184 |
| 123 | MP0002135_abnormal_kidney_morphology | 0.20227804 |
| 124 | MP0001324_abnormal_eye_pigmentation | 0.19298106 |
| 125 | MP0003699_abnormal_female_reproductive | 0.18025741 |
| 126 | MP0005551_abnormal_eye_electrophysiolog | 0.17782051 |
| 127 | MP0003632_abnormal_nervous_system | 0.17374480 |
| 128 | MP0001663_abnormal_digestive_system | 0.16741919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.37792970 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.21523926 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19482922 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.66253775 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.56870529 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.46268647 |
| 7 | Xanthomatosis (HP:0000991) | 6.30543676 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.42987705 |
| 9 | Complement deficiency (HP:0004431) | 5.28212820 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.98835376 |
| 11 | Joint hemorrhage (HP:0005261) | 4.75225840 |
| 12 | Hyperammonemia (HP:0001987) | 4.60657515 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.51668810 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.48150723 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.38753520 |
| 16 | Epidermoid cyst (HP:0200040) | 4.36345104 |
| 17 | Hyperglycinemia (HP:0002154) | 4.32850526 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.27183235 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26048948 |
| 20 | Fat malabsorption (HP:0002630) | 4.21690763 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14447659 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.13647136 |
| 23 | Ketosis (HP:0001946) | 4.10323878 |
| 24 | Hyperglycinuria (HP:0003108) | 4.00069818 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.97347321 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.93957965 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.93957965 |
| 28 | Abnormality of complement system (HP:0005339) | 3.85630697 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77501355 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76723333 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74267099 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.59954952 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36747587 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36033807 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.34590858 |
| 36 | Osteomalacia (HP:0002749) | 3.23857511 |
| 37 | Spontaneous abortion (HP:0005268) | 3.12753701 |
| 38 | Steatorrhea (HP:0002570) | 3.07602640 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02596351 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.00935351 |
| 41 | Delayed CNS myelination (HP:0002188) | 2.95518557 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.95138003 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.94477806 |
| 44 | Ketoacidosis (HP:0001993) | 2.92210060 |
| 45 | Acanthocytosis (HP:0001927) | 2.89548572 |
| 46 | Nephritis (HP:0000123) | 2.89493326 |
| 47 | Hyperphosphaturia (HP:0003109) | 2.81897026 |
| 48 | Metabolic acidosis (HP:0001942) | 2.79734541 |
| 49 | Myocardial infarction (HP:0001658) | 2.79468994 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.70394396 |
| 51 | Skin nodule (HP:0200036) | 2.67336818 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.65532860 |
| 53 | Nausea (HP:0002018) | 2.64454845 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.61272064 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61272064 |
| 56 | Lethargy (HP:0001254) | 2.61168700 |
| 57 | Cholecystitis (HP:0001082) | 2.59326265 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.59326265 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.53275871 |
| 60 | Vascular calcification (HP:0004934) | 2.52179147 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.51787123 |
| 62 | Malnutrition (HP:0004395) | 2.51451800 |
| 63 | Abnormal urine phosphate concentration (HP:0012599) | 2.48417601 |
| 64 | Cholelithiasis (HP:0001081) | 2.47275890 |
| 65 | Amyloidosis (HP:0011034) | 2.44911813 |
| 66 | Pigmentary retinal degeneration (HP:0001146) | 2.41759174 |
| 67 | Cerebral edema (HP:0002181) | 2.40943346 |
| 68 | Spastic diplegia (HP:0001264) | 2.40201331 |
| 69 | Glomerulonephritis (HP:0000099) | 2.39533662 |
| 70 | Gout (HP:0001997) | 2.35043244 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.33654027 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31886039 |
| 73 | Irritability (HP:0000737) | 2.30728577 |
| 74 | Neonatal onset (HP:0003623) | 2.27098117 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.22693010 |
| 76 | Gingival bleeding (HP:0000225) | 2.22633044 |
| 77 | Esophageal varix (HP:0002040) | 2.21911117 |
| 78 | Mitral stenosis (HP:0001718) | 2.21692760 |
| 79 | Poikilocytosis (HP:0004447) | 2.21238944 |
| 80 | Retinal atrophy (HP:0001105) | 2.20449054 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.19651257 |
| 82 | Pancreatitis (HP:0001733) | 2.18572658 |
| 83 | Late onset (HP:0003584) | 2.13099216 |
| 84 | Widely patent fontanelles and sutures (HP:0004492) | 2.09993819 |
| 85 | Menorrhagia (HP:0000132) | 2.09563090 |
| 86 | Thrombophlebitis (HP:0004418) | 2.09214361 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.08341779 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 2.08341779 |
| 89 | Vomiting (HP:0002013) | 2.07897150 |
| 90 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.07805880 |
| 91 | Brushfield spots (HP:0001088) | 2.07576678 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.06783024 |
| 93 | Enlarged kidneys (HP:0000105) | 2.06357567 |
| 94 | Elevated alkaline phosphatase (HP:0003155) | 2.06309181 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 2.05208269 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05118366 |
| 97 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.03561497 |
| 98 | Abnormal tarsal ossification (HP:0008369) | 2.03286994 |
| 99 | Joint swelling (HP:0001386) | 2.00586734 |
| 100 | Abnormality of vitamin B metabolism (HP:0004340) | 1.99403678 |
| 101 | Hemorrhage of the eye (HP:0011885) | 1.98495737 |
| 102 | Opisthotonus (HP:0002179) | 1.96804112 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93039373 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.92562650 |
| 105 | Rickets (HP:0002748) | 1.91567810 |
| 106 | Abnormality of vitamin metabolism (HP:0100508) | 1.91389744 |
| 107 | Nephrolithiasis (HP:0000787) | 1.90032467 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.89417463 |
| 109 | Alkalosis (HP:0001948) | 1.88513811 |
| 110 | Hypophosphatemia (HP:0002148) | 1.88396230 |
| 111 | Facial shape deformation (HP:0011334) | 1.87807515 |
| 112 | Potter facies (HP:0002009) | 1.87807515 |
| 113 | Glycosuria (HP:0003076) | 1.82828699 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 1.82828699 |
| 115 | Renal cortical cysts (HP:0000803) | 1.81516600 |
| 116 | Confusion (HP:0001289) | 1.80236524 |
| 117 | Purpura (HP:0000979) | 1.80079143 |
| 118 | Hypophosphatemic rickets (HP:0004912) | 1.80008963 |
| 119 | Reticulocytosis (HP:0001923) | 1.79979958 |
| 120 | Arthropathy (HP:0003040) | 1.79780478 |
| 121 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78941436 |
| 122 | Proximal tubulopathy (HP:0000114) | 1.78895705 |
| 123 | Elevated hepatic transaminases (HP:0002910) | 1.77872297 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.75655323 |
| 125 | Pulmonary embolism (HP:0002204) | 1.71884626 |
| 126 | Megaloblastic anemia (HP:0001889) | 1.71502746 |
| 127 | Cerebral palsy (HP:0100021) | 1.70921946 |
| 128 | Ileus (HP:0002595) | 1.68283573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.15179017 |
| 2 | ACVR1B | 6.55536085 |
| 3 | PDK2 | 5.05847783 |
| 4 | ERN1 | 4.66815112 |
| 5 | FGFR4 | 4.58455002 |
| 6 | SIK1 | 4.05902300 |
| 7 | TAOK3 | 3.08180171 |
| 8 | ERBB4 | 2.96716415 |
| 9 | MAP3K12 | 2.73147874 |
| 10 | INSRR | 2.66466847 |
| 11 | MST1R | 2.52332348 |
| 12 | MAP2K4 | 2.12838226 |
| 13 | PKN2 | 2.11693153 |
| 14 | FRK | 2.09127087 |
| 15 | MAPK11 | 1.91497070 |
| 16 | MUSK | 1.91010630 |
| 17 | LATS1 | 1.87730382 |
| 18 | TYK2 | 1.80387348 |
| 19 | FLT3 | 1.76313299 |
| 20 | TRIB3 | 1.71806857 |
| 21 | PIK3CG | 1.69854667 |
| 22 | PTK6 | 1.66369053 |
| 23 | PIK3CA | 1.60291350 |
| 24 | NEK9 | 1.54475015 |
| 25 | LMTK2 | 1.54001570 |
| 26 | ABL2 | 1.52170637 |
| 27 | TNIK | 1.45018589 |
| 28 | GRK6 | 1.44512836 |
| 29 | DAPK2 | 1.38968284 |
| 30 | STK39 | 1.34406203 |
| 31 | KDR | 1.30543861 |
| 32 | MYLK | 1.24225255 |
| 33 | NLK | 1.22586456 |
| 34 | MAP3K10 | 1.17311048 |
| 35 | MAP3K7 | 1.16647787 |
| 36 | JAK2 | 1.14706352 |
| 37 | PRKAA2 | 1.10762980 |
| 38 | TBK1 | 1.10150064 |
| 39 | MAP3K3 | 1.08129588 |
| 40 | FGFR2 | 1.05174381 |
| 41 | MET | 1.04851508 |
| 42 | ERBB2 | 1.04040329 |
| 43 | MAP3K11 | 1.03840466 |
| 44 | PINK1 | 1.03779514 |
| 45 | MAP2K3 | 1.03151743 |
| 46 | STK38L | 0.97053891 |
| 47 | MAP3K14 | 0.96837713 |
| 48 | OXSR1 | 0.95102251 |
| 49 | EPHB1 | 0.90610244 |
| 50 | MAPK4 | 0.88808710 |
| 51 | CASK | 0.87295425 |
| 52 | JAK1 | 0.86791781 |
| 53 | MAP2K6 | 0.85784854 |
| 54 | PRKCZ | 0.85735321 |
| 55 | CDK6 | 0.82584039 |
| 56 | RIPK1 | 0.81665590 |
| 57 | NTRK3 | 0.78282397 |
| 58 | MAPK15 | 0.74163263 |
| 59 | BCR | 0.74123589 |
| 60 | PRKACG | 0.72952334 |
| 61 | CAMK2G | 0.72837318 |
| 62 | PTK2 | 0.71250344 |
| 63 | DYRK1B | 0.69961695 |
| 64 | PRKG1 | 0.68114909 |
| 65 | EPHA3 | 0.67547056 |
| 66 | WNK3 | 0.66165462 |
| 67 | TIE1 | 0.66044390 |
| 68 | CSK | 0.64123647 |
| 69 | GSK3A | 0.64060257 |
| 70 | PRKAA1 | 0.63924612 |
| 71 | MAPK12 | 0.63549323 |
| 72 | PDGFRA | 0.63268194 |
| 73 | MAP2K2 | 0.62405320 |
| 74 | RPS6KB1 | 0.60896474 |
| 75 | MAP2K1 | 0.60342318 |
| 76 | TAOK2 | 0.59183994 |
| 77 | PRKCB | 0.58479477 |
| 78 | EIF2AK3 | 0.57554328 |
| 79 | PRKACA | 0.56292262 |
| 80 | NEK6 | 0.56264906 |
| 81 | PBK | 0.55543412 |
| 82 | IRAK3 | 0.55181179 |
| 83 | FER | 0.54304268 |
| 84 | FGFR1 | 0.53521395 |
| 85 | STK16 | 0.52337412 |
| 86 | IKBKE | 0.51747839 |
| 87 | PDPK1 | 0.51438845 |
| 88 | PRKCQ | 0.50394773 |
| 89 | CDK4 | 0.49948864 |
| 90 | SGK3 | 0.47576086 |
| 91 | MAP3K5 | 0.47407378 |
| 92 | CAMK1D | 0.47078372 |
| 93 | GRK1 | 0.46669229 |
| 94 | NEK1 | 0.46626425 |
| 95 | CAMK2D | 0.45526934 |
| 96 | PRKACB | 0.45398464 |
| 97 | PRKCE | 0.45254342 |
| 98 | MAP3K2 | 0.44408723 |
| 99 | SRC | 0.43579624 |
| 100 | CSNK1G1 | 0.43281955 |
| 101 | TRIM28 | 0.43058809 |
| 102 | MATK | 0.42987023 |
| 103 | CSF1R | 0.42794094 |
| 104 | CSNK1A1 | 0.42762045 |
| 105 | EPHB2 | 0.41277246 |
| 106 | MAPK7 | 0.40542192 |
| 107 | TGFBR2 | 0.40444691 |
| 108 | FGFR3 | 0.40398408 |
| 109 | CDK9 | 0.39754692 |
| 110 | MAP3K13 | 0.39029675 |
| 111 | KSR2 | 0.38816911 |
| 112 | MAP3K6 | 0.38560075 |
| 113 | MAPKAPK3 | 0.37978233 |
| 114 | MAP3K1 | 0.36925173 |
| 115 | IGF1R | 0.36420070 |
| 116 | ICK | 0.36087502 |
| 117 | CSNK2A1 | 0.35251682 |
| 118 | RET | 0.34989268 |
| 119 | DAPK3 | 0.34380913 |
| 120 | CSNK2A2 | 0.34367012 |
| 121 | CSNK1D | 0.34277571 |
| 122 | LATS2 | 0.33433232 |
| 123 | EIF2AK1 | 0.32184546 |
| 124 | EPHA2 | 0.32047683 |
| 125 | EGFR | 0.31570050 |
| 126 | CSNK1E | 0.31409200 |
| 127 | MTOR | 0.31345114 |
| 128 | TESK2 | 0.31193779 |
| 129 | PRKCG | 0.30445181 |
| 130 | AKT3 | 0.30304456 |
| 131 | NUAK1 | 0.29888652 |
| 132 | PRKG2 | 0.28826991 |
| 133 | PRKCA | 0.27743529 |
| 134 | PDK1 | 0.27731818 |
| 135 | PAK3 | 0.27007672 |
| 136 | SGK2 | 0.26766486 |
| 137 | BMX | 0.22721678 |
| 138 | EPHA4 | 0.22580971 |
| 139 | CAMK4 | 0.22311808 |
| 140 | SGK494 | 0.21499229 |
| 141 | SGK223 | 0.21499229 |
| 142 | STK3 | 0.20663480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41707177 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55028034 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35772872 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26768514 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07049425 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76559484 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64837152 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64708211 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57045130 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54139384 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48545795 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36553250 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22964745 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16640177 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14378249 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04038189 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96755672 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94019321 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93643014 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88447468 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88281124 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86821366 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76261806 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74272494 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73900043 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73277414 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69382348 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69093161 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68589374 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67748003 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62280826 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56853812 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53857726 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52458568 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.52362254 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50660641 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47234653 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41763235 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36996026 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34763759 |
| 41 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33760891 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32574073 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31784945 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31725124 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22840061 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22145598 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18032540 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.14891840 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09273710 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08683319 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04967544 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01568319 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01229930 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00852792 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00648807 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95722676 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91797302 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85800369 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78194597 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77552705 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76921571 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76737432 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71464564 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67697704 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66961961 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51932657 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48950495 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47607891 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41373621 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39102829 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38971959 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.36807315 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33786134 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25645328 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.19796207 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17447754 |
| 77 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11564111 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.06102042 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05146950 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04987842 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01503051 |
| 82 | * alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.00671045 |
| 83 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2641697 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2363814 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2303128 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.2221360 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2105920 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2086103 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1973160 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1700217 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1672530 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1593749 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1541110 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1444720 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1393977 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1234977 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1227633 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1226722 |
| 99 | * Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1222212 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1221179 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | -0.0955613 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0852252 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0815912 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0786930 |
| 105 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0322288 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0270738 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0084932 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0065218 |

